While on the one hand the lack of other SETD2 co‐occurring mutations in ccRCC such as VHL or PBRM1 in our model allows for more precise definition of functions attributable directly to SETD2, it does not consider how SETD2 activities might be modified by the presence of other mutations. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.